NEW YORK (GenomeWeb News) – Invetech will support the development and manufacture of Biocartis' multiplex platform for biomarker analysis under an agreement announced today.

Invetech will support the development of Biocartis' Evaluation instrument for analyzing protein and nucleic acid-based biomarkers to support clinical research and pharmaceutical applications, the partners said. Evaluation "provides an integrated reaction and detection environment," while enabling the simultaneous investigation of multiple analytes per sample, the companies added.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.